Early research (Phase 1)Study completedNCT00023647What this trial is testingVaccine Therapy in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) Mannkind Corporation 26
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Not applicableStudy completedNCT01715077What this trial is testingStudy of Ipilimumab in the Immune SystemWho this might be right forPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma University Health Network, Toronto 4
Not applicableStudy completedNCT01460875What this trial is testingRecombinant Interferon Alfa-2b in Treating Patients With MelanomaWho this might be right forStage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more William Carson 34
Testing effectiveness (Phase 2)Looking for participantsNCT05428007What this trial is testingInterleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanomaUnresectable Melanoma NYU Langone Health 105
Early research (Phase 1)Study completedNCT00006022What this trial is testingInterleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Virginia Commonwealth University 17
Testing effectiveness (Phase 2)Study completedNCT00871481What this trial is testingLaboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma Fred Hutchinson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01894672What this trial is testingBRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 MutationWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT02296112What this trial is testingTrametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 MutationsWho this might be right forRecurrent MelanomaStage IIIB MelanomaStage IIIC Melanoma+1 more Vanderbilt-Ingram Cancer Center 9
Not applicableLooking for participantsNCT04045691What this trial is testingBinimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma TreatmentWho this might be right forMelanoma Stage IVMelanoma Stage III Pierre Fabre Pharma GmbH 750
Early research (Phase 1)Ended earlyNCT03727789What this trial is testingCBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaWho this might be right forAdvanced Cutaneous Melanoma of the ExtremityAdvanced Sarcoma of the ExtremityClinical Stage III Cutaneous Melanoma AJCC v8+10 more Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT07376317What this trial is testingOptimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)Who this might be right forMelanoma MetastaticMelanoma RecurrentCutaneous Melanoma+1 more Instituto do Cancer do Estado de São Paulo 29
Testing effectiveness (Phase 2)Study completedNCT03873818What this trial is testingLow Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the BrainWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00288041What this trial is testingBortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT01107665What this trial is testingPazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV MelanomaWho this might be right forStage III MelanomaStage IV MelanomaUnresectable Melanoma University of California, Irvine 60
Testing effectiveness (Phase 2)Study completedNCT03620019What this trial is testingDenosumab + PD-1 in Subjects With Stage III/ IV MelanomaWho this might be right forMelanoma Stage IiiMelanoma Stage IvMelanoma+2 more UNC Lineberger Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT02935790What this trial is testingSelective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and NivolumabWho this might be right forMalignant Melanoma Celgene 1
Testing effectiveness (Phase 2)Study completedNCT00104988What this trial is testingS0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin) SWOG Cancer Research Network 64
Early research (Phase 1)Study completedNCT00091143What this trial is testingFludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanoma (Skin) Providence Cancer Center, Earle A. Chiles Research Institute 20
Early research (Phase 1)Study completedNCT02110355What this trial is testingA Phase 1b/2a Study Evaluating AMG 232 in Metastatic MelanomaWho this might be right forAdvanced MalignancyAdvanced Solid TumorsCancer+4 more Kartos Therapeutics, Inc. 31